MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.390
-0.020 (-1.42%)
At close: Oct 23, 2026, 4:00 PM EDT
1.400
+0.010 (0.72%)
After-hours: Oct 23, 2026, 7:30 PM EDT
MediciNova Market Cap
MediciNova has a market cap or net worth of $68.42 million as of October 23, 2026. It is the 27,770th most valuable company in the world and the 4,387th biggest in the United States. Its market cap has increased by 14.41% in one year.
Market Cap
68.42M
Enterprise Value
43.12M
1-Year Change
14.41%
Global Rank
Country Rank
#4,387 United States
Category
ChartMarket Cap Chart
Since December 8, 2006, MediciNova's market cap has decreased from $124.80M to $68.42M, a decrease of -45.18%. That is a compound annual growth rate of -2.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 68.40M | 6.38% |
| Dec 31, 2025 | 64.30M | -37.57% |
| Dec 31, 2024 | 103.00M | 39.95% |
| Dec 29, 2023 | 73.60M | -26.77% |
| Dec 30, 2022 | 100.50M | -23.52% |
| Dec 31, 2021 | 131.40M | -44.39% |
| Dec 31, 2020 | 236.30M | -20.03% |
| Dec 31, 2019 | 295.50M | -13.65% |
| Dec 31, 2018 | 342.20M | 46.49% |
| Dec 29, 2017 | 233.60M | 12.31% |
| Dec 30, 2016 | 208.00M | 95.67% |
| Dec 31, 2015 | 106.30M | 44.43% |
| Dec 31, 2014 | 73.60M | 53.65% |
| Dec 31, 2013 | 47.90M | 69.86% |
| Dec 31, 2012 | 28.20M | 3.30% |
| Dec 30, 2011 | 27.30M | -53.41% |
| Dec 31, 2010 | 58.60M | -31.22% |
| Dec 31, 2009 | 85.20M | 346.07% |
| Dec 31, 2008 | 19.10M | -65.27% |
| Dec 31, 2007 | 55.00M | -59.85% |
| Dec 29, 2006 | 137.00M | 9.78% |
| Dec 8, 2006 | 124.80M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 74.64M |
| Cardiff Oncology | 73.05M |
| NeOnc Technologies Holdings | 72.08M |
| Pelthos Therapeutics | 71.59M |
| Cognition Therapeutics | 71.00M |
| MAIA Biotechnology | 69.34M |
| Spero Therapeutics | 68.13M |
| Cingulate | 67.76M |